WIPO logo
모바일 | Deutsch | English | Español | Français | 日本語 | Português | Русский | 中文 | العربية |
PATENTSCOPE

국제 및 국내 특허문헌 검색
World Intellectual Property Organization
검색
 
열람
 
번역
 
옵션
 
뉴스
 
로그인
 
도움말
 
기계 번역
1. (WO2013059299) ANTIBODIES FOR INTERFERON SUBTYPES AND INTERFERON/INTERFERON RECEPTOR TERNARY COMPLEX AND USES THEREOF
국제사무국에 기록된 최신 서지정보   

공개번호:    WO/2013/059299    국제출원번호:    PCT/US2012/060589
공개일: 25.04.2013 국제출원일: 17.10.2012
IPC:
C07K 16/28 (2006.01), C07K 16/24 (2006.01), C07K 16/18 (2006.01), A61K 39/395 (2006.01), A61P 31/12 (2006.01)
출원인: THE UAB RESEARCH FOUNDATION [US/US]; AB770 1530 3rd Avenue South Birmingham, AL 35294-0107 (US).
THE UNIVERSITY OF TORONTO [CA/CA]; Mars Centre Heritage Building Suite 320 101 College Street Toronto, ON M5G 1L7 (CA)
발명자: WALTER, Mark; (US).
SIDHU, Sachdev; (CA).
MIERSCH, Shane; (CA)
대리인: PRATT, John; Kilpatrick Townsend & Stockton LLP 1100 Peachtree Street Suite 2800 Atlanta, GA 30309-4530 (US)
우선권 정보:
61/547,938 17.10.2011 US
발명의 명칭: (EN) ANTIBODIES FOR INTERFERON SUBTYPES AND INTERFERON/INTERFERON RECEPTOR TERNARY COMPLEX AND USES THEREOF
(FR) ANTICORPS DIRIGÉS CONTRE DIVERS SOUS-TYPES D'INTERFÉRON, COMPLEXE TERNAIRE INTERFÉRON/RÉCEPTEUR D'INTERFÉRON ET UTILISATIONS ASSOCIÉES
요약서: front page image
(EN)Provided herein are antibodies or fragments thereof that specifically bind an interferon-interferon receptor ternary complex. Also provided herein are antibodies or fragments thereof that specifically bind one or two type I interferons. Also provided herein are methods of treating or preventing an autoimmune disease, viral infection, or cancer in a subject comprising administering an effective amount of any of the antibodies described herein to the subject.
(FR)La présente invention concerne des anticorps ou des fragments d'anticorps qui se lient spécifiquement à un complexe ternaire interféron-récepteur d'interféron. L'invention concerne également des anticorps ou des fragments d'anticorps qui se lient spécifiquement à un ou deux interférons de type I. L'invention concerne par ailleurs des méthodes de traitement ou de prévention d'une maladie auto-immune, d'une infection virale ou d'un cancer chez un sujet, lesdites méthodes comprenant l'administration audit sujet d'une quantité efficace de l'un quelconque des anticorps décrits ici.
지정국: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
공개언어: English (EN)
출원언어: English (EN)